Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetics of Hypertension: a Single-centre Randomized Study in Patients With Essential Hypertension Treated With Spironolactone or Torasemide

NCT06413082 is registered in ClinicalTrials.gov with Ospedale San Raffaele as lead sponsor.

NCT NCT06413082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06413082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetics of Hypertension: a Single-centre Randomized Study in Patients With Essential Hypertension Treated With Spironolactone or Torasemide
Lead sponsor
Ospedale San Raffaele
Phase
Phase 3
Overall status
Completed
Start date
February 15, 2021
Completion date
September 3, 2023
Enrollment
38 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

drug effect, genetic predisposition, hypertension